In addition, studies have reported that first-generation once-weekly GLP-1RAs (e.g., exenatide) reduce EAT and hepatic triglyceride content (164)
Legal experts estimate that NAION-related settlements could provide significant compensation ranging from $500,000 to over $1 million, with factors including the severity of vision loss, whether one or both eyes are affected, the patients age and occupation, impact on earning capacity, and quality of life changes
After the administration of single doses of PF-06882961, exploratory analyses revealed a trend for declining post-dose glucose levels at higher doses, with an apparent dose-related trend observed at 24 hours post dose (Fig
Clinical trials show a similar incidence of gallstone-related events for both drugs (around 2.5% for semaglutide and 2.3% for tirzepatide)
The site even names drops a Stanford University doctor endorsing it